ATE113468T1
(de)
|
1987-07-29 |
1994-11-15 |
Liposome Co Inc |
Verfahren zur trennung von teilchen nach grösse.
|
US5542935A
(en)
|
1989-12-22 |
1996-08-06 |
Imarx Pharmaceutical Corp. |
Therapeutic delivery systems related applications
|
US5766635A
(en)
|
1991-06-28 |
1998-06-16 |
Rhone-Poulenc Rorer S.A. |
Process for preparing nanoparticles
|
US5563122A
(en)
|
1991-12-09 |
1996-10-08 |
Asahi Kasei Kogyo Kabushiki Kaisha |
Stabilized parathyroid hormone composition
|
US5302401A
(en)
|
1992-12-09 |
1994-04-12 |
Sterling Winthrop Inc. |
Method to reduce particle size growth during lyophilization
|
US5543158A
(en)
|
1993-07-23 |
1996-08-06 |
Massachusetts Institute Of Technology |
Biodegradable injectable nanoparticles
|
US5565215A
(en)
|
1993-07-23 |
1996-10-15 |
Massachusettes Institute Of Technology |
Biodegradable injectable particles for imaging
|
GB9412273D0
(en)
|
1994-06-18 |
1994-08-10 |
Univ Nottingham |
Administration means
|
US6007845A
(en)
|
1994-07-22 |
1999-12-28 |
Massachusetts Institute Of Technology |
Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers
|
AU4755696A
(en)
|
1995-01-05 |
1996-07-24 |
Board Of Regents Acting For And On Behalf Of The University Of Michigan, The |
Surface-modified nanoparticles and method of making and using same
|
JP4979843B2
(ja)
|
1995-03-10 |
2012-07-18 |
ロッシュ ディアグノスティクス ゲゼルシャフト ミット ベシュレンクテル ハフツング |
微粒子の形のポリペプチド含有投薬形
|
US6902743B1
(en)
|
1995-05-22 |
2005-06-07 |
The United States Of America As Represented By The Secretary Of The Army |
Therapeutic treatment and prevention of infections with a bioactive material(s) encapuslated within a biodegradable-bio-compatable polymeric matrix
|
US7422902B1
(en)
|
1995-06-07 |
2008-09-09 |
The University Of British Columbia |
Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
|
FR2742357B1
(fr)
|
1995-12-19 |
1998-01-09 |
Rhone Poulenc Rorer Sa |
Nanoparticules stabilisees et filtrables dans des conditions steriles
|
US5792477A
(en)
|
1996-05-07 |
1998-08-11 |
Alkermes Controlled Therapeutics, Inc. Ii |
Preparation of extended shelf-life biodegradable, biocompatible microparticles containing a biologically active agent
|
US8038994B2
(en)
|
1996-05-15 |
2011-10-18 |
Quest Pharmatech Inc. |
Combination therapy for treating disease
|
JP2942508B2
(ja)
|
1997-01-14 |
1999-08-30 |
順也 藤森 |
温度感受性徐放性基剤及び温度感受性徐放性システム
|
US6201072B1
(en)
|
1997-10-03 |
2001-03-13 |
Macromed, Inc. |
Biodegradable low molecular weight triblock poly(lactide-co- glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
|
US6254890B1
(en)
|
1997-12-12 |
2001-07-03 |
Massachusetts Institute Of Technology |
Sub-100nm biodegradable polymer spheres capable of transporting and releasing nucleic acids
|
US6541606B2
(en)
|
1997-12-31 |
2003-04-01 |
Altus Biologics Inc. |
Stabilized protein crystals formulations containing them and methods of making them
|
JP2002519333A
(ja)
|
1998-06-30 |
2002-07-02 |
アムジエン・インコーポレーテツド |
生物学的に活性な物質の徐放運搬のための感熱性生分解性ヒドロゲル
|
US6265609B1
(en)
|
1998-07-06 |
2001-07-24 |
Guilford Pharmaceuticals Inc. |
Thio-substituted pentanedioic acid derivatives
|
US6395718B1
(en)
|
1998-07-06 |
2002-05-28 |
Guilford Pharmaceuticals Inc. |
Pharmaceutical compositions and methods of inhibiting angiogenesis using naaladase inhibitors
|
KR100274842B1
(ko)
|
1998-10-01 |
2001-03-02 |
김효근 |
미립구를 이용한 레티노익산의 서방형 약물방출 시스템
|
DE19856432A1
(de)
|
1998-12-08 |
2000-06-15 |
Basf Ag |
Nanopartikuläre Kern-Schale Systeme sowie deren Verwendung in pharmazeutischen und kosmetischen Zubereitungen
|
FI982733A
(fi)
*
|
1998-12-17 |
2000-06-18 |
Orion Yhtymae Oyj |
Trifenyylietyleeniantiestrogeenien liukoisia koostumuksia
|
US7311924B2
(en)
|
1999-04-01 |
2007-12-25 |
Hana Biosciences, Inc. |
Compositions and methods for treating cancer
|
US6528499B1
(en)
|
2000-04-27 |
2003-03-04 |
Georgetown University |
Ligands for metabotropic glutamate receptors and inhibitors of NAALADase
|
CA2321321A1
(en)
|
1999-09-30 |
2001-03-30 |
Isotis B.V. |
Polymers loaded with bioactive agents
|
US6136846A
(en)
|
1999-10-25 |
2000-10-24 |
Supergen, Inc. |
Formulation for paclitaxel
|
US20050037086A1
(en)
|
1999-11-19 |
2005-02-17 |
Zycos Inc., A Delaware Corporation |
Continuous-flow method for preparing microparticles
|
KR100416242B1
(ko)
|
1999-12-22 |
2004-01-31 |
주식회사 삼양사 |
약물전달체용 생분해성 블록 공중합체의 액체 조성물 및이의 제조방법
|
US6890946B2
(en)
|
1999-12-23 |
2005-05-10 |
Indiana University Research And Technology Corporation |
Use of parthenolide to inhibit cancer
|
US7217770B2
(en)
|
2000-05-17 |
2007-05-15 |
Samyang Corporation |
Stable polymeric micelle-type drug composition and method for the preparation thereof
|
US6495164B1
(en)
|
2000-05-25 |
2002-12-17 |
Alkermes Controlled Therapeutics, Inc. I |
Preparation of injectable suspensions having improved injectability
|
KR100418916B1
(ko)
|
2000-11-28 |
2004-02-14 |
한국과학기술원 |
생분해성 고분자와 항암제의 접합체를 이용한 서방형미셀제제의 제조방법
|
KR100446101B1
(ko)
|
2000-12-07 |
2004-08-30 |
주식회사 삼양사 |
수난용성 약물의 서방성 제형 조성물
|
AU2002232824A1
(en)
|
2000-12-21 |
2002-07-01 |
Inhale Therapeutic Systems, Inc. |
Induced phase transition method for the production of microparticles containing hydrophobic active agents
|
US6623761B2
(en)
|
2000-12-22 |
2003-09-23 |
Hassan Emadeldin M. |
Method of making nanoparticles of substantially water insoluble materials
|
DK1345597T3
(da)
|
2000-12-27 |
2007-12-10 |
Ares Trading Sa |
Amfifile lipidanopartikler til peptid- og/eller proteininkorporering
|
CA2436408A1
(en)
|
2001-02-07 |
2002-12-12 |
Beth Israel Deaconess Medical Center |
Modified psma ligands and uses related thereto
|
WO2002080846A2
(en)
|
2001-04-03 |
2002-10-17 |
Kosan Biosciences, Inc. |
Epothilone derivatives and methods for making and using the same
|
JP2005500304A
(ja)
|
2001-06-21 |
2005-01-06 |
アルタス バイオロジックス インコーポレイテッド |
球状タンパク質粒子およびそれらの作製方法および使用方法
|
WO2003017987A1
(en)
|
2001-08-31 |
2003-03-06 |
Mcgill University |
Biodegradable polymeric nanocapsules and uses thereof
|
US6592899B2
(en)
|
2001-10-03 |
2003-07-15 |
Macromed Incorporated |
PLA/PLGA oligomers combined with block copolymers for enhancing solubility of a drug in water
|
WO2003030870A1
(fr)
|
2001-10-10 |
2003-04-17 |
Pierre Fabre Medicament |
Microspheres biodegradables a liberation prolongee et leur procede de preparation
|
CA2461556A1
(en)
|
2001-10-15 |
2003-04-24 |
Crititech, Inc. |
Compositions and methods for delivery of microparticles of poorly water soluble drugs and methods of treatment
|
US20030235619A1
(en)
|
2001-12-21 |
2003-12-25 |
Christine Allen |
Polymer-lipid delivery vehicles
|
EP1458365A1
(en)
|
2001-12-21 |
2004-09-22 |
Celator Technologies Inc. |
Improved polymer-lipid delivery vehicles
|
EP1472541B1
(en)
|
2002-01-10 |
2009-09-16 |
The Johns Hopkins University |
Imaging agents and methods of imaging naaladase of psma
|
US20060165987A1
(en)
|
2002-04-05 |
2006-07-27 |
Patrice Hildgen |
Stealthy polymeric biodegradable nanospheres and uses thereof
|
US20030232887A1
(en)
|
2002-04-10 |
2003-12-18 |
Johnson Douglas Giles |
Preparation and use of a stable formulation of allosteric effector compounds
|
AU2003228666A1
(en)
|
2002-04-23 |
2003-11-10 |
Case Western Reserve University |
Lapachone delivery systems, compositions and uses related thereto
|
JP2003342168A
(ja)
|
2002-05-24 |
2003-12-03 |
Nano Career Kk |
注射用薬物含有ポリマーミセル製剤の製造方法
|
ATE424795T1
(de)
|
2002-06-05 |
2009-03-15 |
Univ Florida |
Ophthalmisches arzneimittelabgabesystem
|
US7767803B2
(en)
|
2002-06-18 |
2010-08-03 |
Archemix Corp. |
Stabilized aptamers to PSMA and their use as prostate cancer therapeutics
|
JP4530626B2
(ja)
*
|
2002-06-25 |
2010-08-25 |
武田薬品工業株式会社 |
徐放性組成物の製造方法
|
US7879351B2
(en)
|
2002-10-29 |
2011-02-01 |
Transave, Inc. |
High delivery rates for lipid based drug formulations, and methods of treatment thereof
|
US20040220081A1
(en)
|
2002-10-30 |
2004-11-04 |
Spherics, Inc. |
Nanoparticulate bioactive agents
|
JP4917263B2
(ja)
|
2002-12-23 |
2012-04-18 |
バイカル インコーポレイテッド |
核酸/ブロックコポリマー/陽イオン性界面活性剤複合体を凍結乾燥する方法
|
US6841547B2
(en)
|
2003-02-28 |
2005-01-11 |
Albert Einstein College Of Medicine Of Yeshevia University |
Method for decreasing low density lipoprotein
|
US20040185170A1
(en)
|
2003-03-21 |
2004-09-23 |
Shubha Chungi |
Method for coating drug-containing particles and formulations and dosage units formed therefrom
|
JP2006521367A
(ja)
|
2003-03-26 |
2006-09-21 |
株式会社Lttバイオファーマ |
ターゲッティングと徐放を目的とした静脈注射用ナノ粒子
|
DE602004025159D1
(de)
|
2003-03-26 |
2010-03-04 |
Egalet As |
Matrixzubereitungen für die kontrollierte Darreichung von Arzneistoffen
|
JP4927535B2
(ja)
|
2003-04-03 |
2012-05-09 |
ジェシー エル エス オウ |
腫瘍を標的指向化する薬物を封入した粒子
|
US20040247624A1
(en)
|
2003-06-05 |
2004-12-09 |
Unger Evan Charles |
Methods of making pharmaceutical formulations for the delivery of drugs having low aqueous solubility
|
US7727969B2
(en)
|
2003-06-06 |
2010-06-01 |
Massachusetts Institute Of Technology |
Controlled release nanoparticle having bound oligonucleotide for targeted delivery
|
US20050256071A1
(en)
|
2003-07-15 |
2005-11-17 |
California Institute Of Technology |
Inhibitor nucleic acids
|
CA2819769C
(en)
*
|
2003-07-18 |
2016-06-28 |
Oakwood Laboratories, L.L.C. |
Prevention of molecular weight reduction of the polymer, impurity formation and gelling in polymer compositions
|
US20050142205A1
(en)
|
2003-07-18 |
2005-06-30 |
Julia Rashba-Step |
Methods for encapsulating small spherical particles prepared by controlled phase separation
|
JP5165240B2
(ja)
|
2003-07-23 |
2013-03-21 |
ピーアール ファーマシューティカルズ, インコーポレイテッド |
徐放組成物
|
MXPA06002393A
(es)
|
2003-09-02 |
2006-06-20 |
Novartis Ag |
Tratamiento de cancer con epotilomas.
|
US7311901B2
(en)
|
2003-10-10 |
2007-12-25 |
Samyang Corporation |
Amphiphilic block copolymer and polymeric composition comprising the same for drug delivery
|
US7846412B2
(en)
|
2003-12-22 |
2010-12-07 |
Emory University |
Bioconjugated nanostructures, methods of fabrication thereof, and methods of use thereof
|
US20050266067A1
(en)
|
2004-03-02 |
2005-12-01 |
Shiladitya Sengupta |
Nanocell drug delivery system
|
US20070053845A1
(en)
|
2004-03-02 |
2007-03-08 |
Shiladitya Sengupta |
Nanocell drug delivery system
|
US8043631B2
(en)
|
2004-04-02 |
2011-10-25 |
Au Jessie L S |
Tumor targeting drug-loaded particles
|
US20080124400A1
(en)
|
2004-06-24 |
2008-05-29 |
Angiotech International Ag |
Microparticles With High Loadings Of A Bioactive Agent
|
AU2005326322B2
(en)
|
2004-07-01 |
2009-02-05 |
Yale University |
Targeted and high density drug loaded polymeric materials
|
US7473678B2
(en)
|
2004-10-14 |
2009-01-06 |
Biomimetic Therapeutics, Inc. |
Platelet-derived growth factor compositions and methods of use thereof
|
JP2006131577A
(ja)
|
2004-11-09 |
2006-05-25 |
Ltt Bio-Pharma Co Ltd |
異なる粒子径を有する薬物封入ナノ粒子の作製方法および当該方法で得られたナノ粒子
|
KR20070104574A
(ko)
|
2004-12-30 |
2007-10-26 |
신벤션 아게 |
신호를 제공하는 제제, 임플란트 재료 및 약물을 포함하는조합물
|
WO2006093991A1
(en)
|
2005-03-02 |
2006-09-08 |
The Cleveland Clinic Foundation |
Compounds which bind psma and uses thereof
|
WO2006107957A2
(en)
|
2005-04-04 |
2006-10-12 |
Sinexus, Inc. |
Device and methods for treating paranasal sinus conditions
|
JP2006321763A
(ja)
|
2005-05-20 |
2006-11-30 |
Hosokawa Funtai Gijutsu Kenkyusho:Kk |
生体適合性ナノ粒子及びその製造方法
|
CN102016814B
(zh)
|
2005-06-17 |
2013-10-23 |
北卡罗来纳大学查珀尔希尔分校 |
纳米粒子制备方法、系统及材料
|
EP1902014A2
(en)
|
2005-07-11 |
2008-03-26 |
Wyeth |
Glutamate aggrecanase inhibitors
|
EP1917030A4
(en)
|
2005-08-03 |
2011-03-09 |
Immunogen Inc |
IMMUNKONJUGATFORMULIERUNGEN
|
WO2007027941A2
(en)
|
2005-08-31 |
2007-03-08 |
Abraxis Bioscience, Llc. |
Compositions and methods for preparation of poorly water soluble drugs with increased stability
|
WO2007028341A1
(fr)
|
2005-09-09 |
2007-03-15 |
Beijing Diacrid Medical Technology Co., Ltd. |
Nanomicelles servant de medicaments anticancereux a polyethylene phospholipides glycolyles contenant des vinca alcaloides
|
US20090022806A1
(en)
|
2006-12-22 |
2009-01-22 |
Mousa Shaker A |
Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists and formulations and uses thereof
|
EP1996234A2
(en)
|
2005-09-20 |
2008-12-03 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Nanoparticles for targeted delivery of active agents
|
US8916206B2
(en)
|
2005-12-26 |
2014-12-23 |
Ltt Bio-Pharma Co., Ltd. |
Nanoparticles containing water-soluble non-peptide low-molecular weight drug
|
US7842312B2
(en)
|
2005-12-29 |
2010-11-30 |
Cordis Corporation |
Polymeric compositions comprising therapeutic agents in crystalline phases, and methods of forming the same
|
US20090155349A1
(en)
|
2006-02-23 |
2009-06-18 |
Jonathan Daniel Heller |
Methods of treating influenza viral infections
|
DE102006013531A1
(de)
|
2006-03-24 |
2007-09-27 |
Lts Lohmann Therapie-Systeme Ag |
Polylactid-Nanopartikel
|
JP2009534309A
(ja)
|
2006-03-31 |
2009-09-24 |
マサチューセッツ インスティテュート オブ テクノロジー |
治療剤の標的化送達のためのシステム
|
EP2019691B1
(en)
|
2006-05-15 |
2020-08-12 |
Massachusetts Institute of Technology |
Polymers for functional particles
|
CA2657817C
(en)
|
2006-07-26 |
2016-05-31 |
Sandoz Ag |
Caspofungin formulations
|
US20090247552A1
(en)
|
2006-07-31 |
2009-10-01 |
Shirou Sawa |
Aqueous liquid preparation containing amide compound
|
JP2010511595A
(ja)
|
2006-07-31 |
2010-04-15 |
ニューロシステック コーポレイション |
遊離塩基ガシクリジンナノ粒子
|
US20100144845A1
(en)
|
2006-08-04 |
2010-06-10 |
Massachusetts Institute Of Technology |
Oligonucleotide systems for targeted intracellular delivery
|
US20080057102A1
(en)
|
2006-08-21 |
2008-03-06 |
Wouter Roorda |
Methods of manufacturing medical devices for controlled drug release
|
WO2008038944A1
(en)
|
2006-09-26 |
2008-04-03 |
Samyang Corporation |
Submicron nanoparticle of poorly water soluble camptothecin derivatives and process for preparation thereof
|
EP4023624A1
(en)
|
2006-11-08 |
2022-07-06 |
Molecular Insight Pharmaceuticals, Inc. |
Heterodimers of glutamic acid
|
WO2008147456A2
(en)
|
2006-11-20 |
2008-12-04 |
Massachusetts Institute Of Technology |
Drug delivery systems using fc fragments
|
CN1957911A
(zh)
|
2006-12-01 |
2007-05-09 |
济南康泉医药科技有限公司 |
一种抗实体肿瘤缓释剂
|
CN1969818A
(zh)
|
2006-12-12 |
2007-05-30 |
济南帅华医药科技有限公司 |
一种含埃坡霉素衍生物的抗癌缓释注射剂
|
CN1961864A
(zh)
|
2006-12-12 |
2007-05-16 |
济南帅华医药科技有限公司 |
一种抗癌的组合物
|
CN101396342A
(zh)
|
2006-12-12 |
2009-04-01 |
济南帅华医药科技有限公司 |
含埃坡霉素衍生物的抗癌缓释注射剂
|
CN101396340A
(zh)
|
2006-12-12 |
2009-04-01 |
济南帅华医药科技有限公司 |
一种含埃坡霉素衍生物的抗癌缓释注射剂
|
CN1969816A
(zh)
|
2006-12-12 |
2007-05-30 |
济南帅华医药科技有限公司 |
一种含埃坡霉素的抗癌缓释剂
|
CN101433520A
(zh)
|
2006-12-12 |
2009-05-20 |
济南帅华医药科技有限公司 |
含埃坡霉素的抗癌缓释剂
|
US20100015050A1
(en)
|
2006-12-21 |
2010-01-21 |
Wayne State University |
Peg and targeting ligands on nanoparticle surface
|
CA3006137C
(en)
|
2007-03-07 |
2023-08-01 |
Abraxis Bioscience, Llc. |
Nanoparticle comprising rapamycin and albumin as anticancer agent
|
CN101053553B
(zh)
|
2007-03-16 |
2011-04-20 |
吉林大学 |
一种生物可降解氟尿嘧啶聚酯载药纳米球及其制备方法
|
WO2008124634A1
(en)
|
2007-04-04 |
2008-10-16 |
Massachusetts Institute Of Technology |
Polymer-encapsulated reverse micelles
|
US20090074828A1
(en)
|
2007-04-04 |
2009-03-19 |
Massachusetts Institute Of Technology |
Poly(amino acid) targeting moieties
|
JP5248487B2
(ja)
|
2007-05-14 |
2013-07-31 |
株式会社Lttバイオファーマ |
徐放性の陰荷電基を持つ低分子薬物含有ナノ粒子
|
WO2008151245A1
(en)
|
2007-06-04 |
2008-12-11 |
Sun Chemical Corporation |
Dispersions for plastic films
|
CN101835492B
(zh)
|
2007-08-21 |
2012-11-21 |
德克萨斯州立大学董事会 |
用于制药应用的热动力学混合
|
US20090061009A1
(en)
|
2007-08-29 |
2009-03-05 |
Joseph Schwarz |
Composition and Method of Treatment of Bacterial Infections
|
PL2644192T3
(pl)
|
2007-09-28 |
2017-09-29 |
Pfizer Inc. |
Ukierunkowanie na komórki nowotworowe z zastosowaniem nanocząstek
|
US20090306120A1
(en)
|
2007-10-23 |
2009-12-10 |
Florencia Lim |
Terpolymers containing lactide and glycolide
|
US8974814B2
(en)
|
2007-11-12 |
2015-03-10 |
California Institute Of Technology |
Layered drug delivery polymer monofilament fibers
|
WO2009070302A1
(en)
|
2007-11-30 |
2009-06-04 |
The Johns Hopkins University |
Prostate specific membrane antigen (psma) targeted nanoparticles for therapy of prostate cancer
|
DE102007059752A1
(de)
|
2007-12-10 |
2009-06-18 |
Bayer Schering Pharma Aktiengesellschaft |
Funktionalisierte, feste Polymernanopartikel enthaltend Epothilone
|
WO2009084801A1
(en)
|
2007-12-31 |
2009-07-09 |
Samyang Corporation |
Amphiphilic block copolymer micelle composition containing taxane and manufacturing process of the same
|
EP2106806A1
(en)
|
2008-03-31 |
2009-10-07 |
Fraunhofer-Gesellschaft zur Förderung der Angewandten Forschung e.V. |
Nanoparticles for targeted delivery of active agents to the lung
|
US20090312402A1
(en)
|
2008-05-20 |
2009-12-17 |
Contag Christopher H |
Encapsulated nanoparticles for drug delivery
|
EA020753B1
(ru)
|
2008-06-16 |
2015-01-30 |
Бинд Терапьютикс, Инк. |
Терапевтические полимерные наночастицы, содержащие алкалоиды vinca, и их применение
|
DK2285350T3
(en)
|
2008-06-16 |
2017-12-11 |
Pfizer |
PROCEDURES FOR THE PREPARATION OF DIBLOCK COPOLYMERS FUNCTIONALIZED WITH TARGETING AGENT FOR USE IN THE MANUFACTURE OF THERAPEUTIC NANOPARTICLES
|
CN102099016A
(zh)
*
|
2008-06-16 |
2011-06-15 |
佰恩德生物科学股份有限公司 |
载药的聚合物纳米微粒及其制备和使用方法
|
WO2010005726A2
(en)
|
2008-06-16 |
2010-01-14 |
Bind Biosciences Inc. |
Therapeutic polymeric nanoparticles with mtor inhibitors and methods of making and using same
|
DK2774608T3
(da)
|
2008-06-16 |
2020-01-13 |
Pfizer |
Lægemiddelladede polymere nanopartikler og fremgangsmåder til fremstilling og anvendelse deraf
|
CA2728909A1
(en)
|
2008-07-08 |
2010-01-14 |
Abbott Laboratories |
Prostaglandin e2 binding proteins and uses thereof
|
US20100087337A1
(en)
|
2008-09-10 |
2010-04-08 |
Bind Biosciences, Inc. |
High Throughput Fabrication of Nanoparticles
|
US20110125090A1
(en)
|
2008-11-13 |
2011-05-26 |
Peyman Gholam A |
Ophthalmic drug delivery system and method
|
US8563041B2
(en)
|
2008-12-12 |
2013-10-22 |
Bind Therapeutics, Inc. |
Therapeutic particles suitable for parenteral administration and methods of making and using same
|
JP2012512175A
(ja)
|
2008-12-15 |
2012-05-31 |
バインド バイオサイエンシズ インコーポレイテッド |
治療薬を徐放するための長時間循環性ナノ粒子
|
JP2012522055A
(ja)
|
2009-03-30 |
2012-09-20 |
セルリアン・ファーマ・インコーポレイテッド |
ポリマー‐薬剤抱合体、粒子、組成物、および関連する使用方法
|
WO2010114770A1
(en)
|
2009-03-30 |
2010-10-07 |
Cerulean Pharma Inc. |
Polymer-agent conjugates, particles, compositions, and related methods of use
|
WO2010114768A1
(en)
|
2009-03-30 |
2010-10-07 |
Cerulean Pharma Inc. |
Polymer-epothilone conjugates, particles, compositions, and related methods of use
|
HUE032426T2
(en)
|
2009-05-27 |
2017-09-28 |
Alkermes Pharma Ireland Ltd |
Inhibition of flake aggregation in nanoparticulate meloxicam formulations
|
US7772274B1
(en)
*
|
2009-10-19 |
2010-08-10 |
Scidose, Llc |
Docetaxel formulations with lipoic acid
|
CN102811743B
(zh)
|
2009-12-11 |
2015-11-25 |
佰恩德治疗股份有限公司 |
冻干治疗颗粒的稳定制剂
|
EP2512459A4
(en)
|
2009-12-15 |
2013-08-07 |
|
THERAPEUTIC POLYMERIC NANOPARTICLES COMPRISING EPOTHILONE AND METHODS OF MAKING AND USING SAME
|
EP2512487A4
(en)
|
2009-12-15 |
2013-08-07 |
|
THERAPEUTIC POLYMERNANOPARTICLES WITH CORTICOSTEROIDS AND METHOD FOR THE PRODUCTION AND USE THEREOF
|
EA201290499A1
(ru)
|
2009-12-15 |
2013-01-30 |
Байнд Байосайенсиз, Инк. |
Композиции терапевтических полимерных наночастиц с высокой температурой стеклования и высокомолекулярными сополимерами
|
WO2011079279A2
(en)
|
2009-12-23 |
2011-06-30 |
Board Of Trustees Of The University Of Illinois |
Nanoconjugates and nanoconjugate formulations
|
WO2011119995A2
(en)
|
2010-03-26 |
2011-09-29 |
Cerulean Pharma Inc. |
Formulations and methods of use
|
WO2012040513A1
(en)
|
2010-09-22 |
2012-03-29 |
The Board Of Regents Of The University Of Texas System |
Compositions and methods for the delivery of beta lapachone
|
JP2013543844A
(ja)
*
|
2010-10-22 |
2013-12-09 |
バインド セラピューティックス インコーポレイテッド |
高分子コポリマーを含む治療用ナノ粒子
|
US20140308363A1
(en)
|
2011-05-31 |
2014-10-16 |
Bind Therapeutics, Inc. |
Drug loaded polymeric nanoparticles and methods of making and using same
|
JP2014531456A
(ja)
|
2011-09-22 |
2014-11-27 |
バインド セラピューティックス インコーポレイテッド |
治療用ナノ粒子と癌を治療する方法
|
EP4218740A1
(en)
|
2012-01-13 |
2023-08-02 |
XSpray Pharma AB (publ) |
Novel compositions
|
CN104136012B
(zh)
*
|
2012-02-29 |
2019-07-12 |
默克专利股份有限公司 |
制备装载有活性物质的纳米颗粒的方法
|
BR112015005878A2
(pt)
|
2012-09-17 |
2017-07-04 |
Bind Therapeutics Inc |
nanopartículas terapêuticas compreendendo agente terapêutico e métodos de preparar e usar as mesmas
|
HUE043998T2
(hu)
|
2012-09-17 |
2019-09-30 |
Pfizer |
Eljárás terápiás nanorészecskék elõállítására
|